RIVKA BORTZ: Open Payments
NPI 1437708286 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 15 payments from 8 companies in 2025. Trend: 2023 $758 · 2024 $453 · 2025 $335
Food & beverage: $316Education: $19
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $87 |
| Lilly USA, LLC | 4 | $84 |
| Exact Sciences Corporation | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Seqirus USA Inc | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: MOUNJARO, Ozempic, Cologuard Collection Kit, LEQVIO, Rybelsus, BREZTRI, Fluad, JARDIANCE.
Industry payments across MD — which companies pay providers there.
